Risk-Conferring Glutamatergic Genes and Brain Glutamate Plus Glutamine in Schizophrenia

@article{Bustillo2017RiskConferringGG,
  title={Risk-Conferring Glutamatergic Genes and Brain Glutamate Plus Glutamine in Schizophrenia},
  author={Juan R. Bustillo and Veena Patel and Thomas R. Jones and Rex E. Jung and Nattida Payaknait and Clifford Qualls and Jos{\'e} M. Ca{\~n}ive and Jingyu Liu and Nora I. Perrone-Bizzozero and Vince D. Calhoun and Jessica A. Turner and Charles Gasparovic},
  journal={Frontiers in Psychiatry},
  year={2017},
  volume={8}
}
Background The proton magnetic resonance spectroscopy (1H-MRS) signals from glutamate (or the combined glutamate and glutamine signal—Glx) have been found to be greater in various brain regions in people with schizophrenia. Recently, the Psychiatric Genetics Consortium reported that several common single-nucleotide polymorphisms (SNPs) in glutamate-related genes confer increased risk of schizophrenia. Here, we examined the relationship between presence of these risk polymorphisms and brain Glx… 
Heritability of cerebral glutamate levels and their association with schizophrenia spectrum disorders: a 1[H]-spectroscopy twin study
TLDR
Increases in thalamic glutamate levels found in schizophrenia spectrum disorders are explained by genetic influences related to the disease, and as such the measure could be a potential marker of genetic susceptibility, useful in early detection and stratification of patients with psychosis.
Mapping the Schizophrenia Genes by Neuroimaging: The Opportunities and the Challenges
  • A. Arslan
  • Biology, Psychology
    International journal of molecular sciences
  • 2018
Schizophrenia (SZ) is a heritable brain disease originating from a complex interaction of genetic and environmental factors. The genes underpinning the neurobiology of SZ are largely unknown but
Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial
TLDR
These findings demonstrate robust effects of ketamine on pharmacoBOLD across sites, supporting its utility for definitive assessment of functional target engagement.
The genome-wide supported CACNA1C gene polymorphisms and the risk of schizophrenia: an updated meta-analysis
TLDR
The present study focused on whether there was an ancestral difference in the effect of the CACNA1C gene rs1006737 on schizophrenia, and found that the genotypes GG and GG + GA were only protective factors for schizophrenia in Europeans, while the rs 1006737 GA genotype only reduced the risk of schizophrenia in Asians.
Genetic Associations between Voltage-Gated Calcium Channels and Psychiatric Disorders
TLDR
A general overview of CaVs structure, classification, function, expression and pharmacology, and pharmacological evidence of the use of CaV modulators to treat psychiatric disorders are provided.
Fearful dogs have increased plasma glutamine and γ-glutamyl glutamine
TLDR
A novel breed-specific association between renal biomarker symmetric dimethylarginine (SDMA) and canine fearfulness is described and observed, which may result from high levels of prolonged psychological stress in fearful dogs.
Genome-wide association study of smoking trajectory and meta-analysis of smoking status in 842,000 individuals
TLDR
A large genome-wide association study for longitudinal smoking phenotypes in 286,118 individuals from the Million Veteran Program, combined with a meta-GWAS for smoking status, adds new insights into the genetic vulnerability for smoking behavior.
Single-step genome-wide association study for social genetic effects and direct genetic effects on growth in Landrace pigs
TLDR
The results of biological pathway and gene network analyses support the association of the neuropsychiatric processes with SGE on ADG in pigs and provide important insights that can help facilitate a better understanding of the molecular basis of SGE for socially affected traits.
University of Birmingham Oxidative stress and the pathophysiology and symptom profile of schizophrenia spectrum disorders
TLDR
This document is for the purpose of private study or non-commercial research, and users may not further distribute the material nor use it for the purposes of commercial gain.
...
...

References

SHOWING 1-10 OF 32 REFERENCES
Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.
TLDR
The hypothesis that schizophrenia is associated with excess glutamatergic neurotransmission in several limbic areas is supported and indicates that compounds that reduce glutamatorgic transmission may have therapeutic potential.
Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system
TLDR
Findings provide first in vivo evidence for an effect of the functional BDNF val66met polymorphism on the glutamate system in human hippocampus, independently of psychiatric diagnoses.
Associations Between Recent Heavy Drinking and Dorsal Anterior Cingulate N-Acetylaspartate and Glutamate Concentrations in Non-Treatment-Seeking Individuals with Alcohol Dependence.
TLDR
In inverse associations between recent heavy drinking and dACC glutamate and NAA concentrations in a sample of nonsevere, non- treatment-seeking individuals with AD are demonstrated, which may support the hypothesis that amount of recent alcohol consumption may account for differences in neuronal metabolism, even in non severe,non-treatment-seeking alcoholics.
Biological Insights From 108 Schizophrenia-Associated Genetic Loci
TLDR
Associations at DRD2 and several genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses.
Schizophrenia genes: on the matter of their convergence.
  • D. Rujescu
  • Biology
    Current topics in behavioral neurosciences
  • 2012
TLDR
The knowledge resulting from the availability of the complete sequence of the human genome, the systematic identification of single nucleotide polymorphisms (SNPs) throughout the genome, and the development of parallel genotyping technology (microarrays) established the conditions that brought about the current successful time in ability to probe the genome for identifying disease genes.
...
...